GlassScriptPhysician profile
Aaron Avallone
NPI 1366646069
$1,406.79
in general payments reported to CMS, 2019-2025
14 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $195 · 2021: $493 · 2022: $75.88 · 2023: $34.37 · 2024: $108 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $477.38 | 2021-2025 | Vraylar |
| Allergan, INC. | $236.87 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $165.49 | 2021-2025 | Rexulti |
| Neurocrine Biosciences, INC. | $118.65 | 2019-2021 | |
| Eisai INC. | $89.24 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $68.71 | 2021 | |
| Alkermes, INC. | $52.18 | 2020-2021 | |
| Bausch Health US, LLC | $44.46 | 2021 | |
| Avanir Pharmaceuticals, INC. | $40.17 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.79 | 2021 | |
| Axsome Therapeutics, INC. | $27.38 | 2025 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $20.22 | 2022 | |
| Lundbeck LLC | $15.76 | 2020 | |
| Jazz Pharmaceuticals INC. | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Avallone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.